159 related articles for article (PubMed ID: 38054827)
1.
Lin C; Lin Y; Wang S; Wang J; Mao X; Zhou Y; Zhang H; Chen W; Wang G
Food Funct; 2024 Jan; 15(1):236-254. PubMed ID: 38054827
[No Abstract] [Full Text] [Related]
2. Assessment of the role and mechanism of Bifidobacterium animalis subsp. lactis isolated from neonates' feces in protecting neonatal rats from Salmonella infection.
Lin Y; Xie Z; Li Z; Yuan C; Zhang C; Li Y; Xie K; Wang K
Microb Pathog; 2023 Jan; 174():105935. PubMed ID: 36509312
[TBL] [Abstract][Full Text] [Related]
3. The microbiota-gut-brain axis: A crucial immunomodulatory pathway for Bifidobacterium animalis subsp. lactis' resilience against LPS treatment in neonatal rats.
Lin Y; Xie Z; Li Z; Yuan C; Zhang C; Li Y; Xie K; Wang K
Int J Biol Macromol; 2024 May; 266(Pt 2):131255. PubMed ID: 38556221
[TBL] [Abstract][Full Text] [Related]
4. Xylo-oligosaccharide alleviates Salmonella induced inflammation by stimulating Bifidobacterium animalis and inhibiting Salmonella colonization.
Pang J; Wang S; Wang Z; Wu Y; Zhang X; Pi Y; Han D; Zhang S; Wang J
FASEB J; 2021 Nov; 35(11):e21977. PubMed ID: 34613640
[TBL] [Abstract][Full Text] [Related]
5. Anti-obesity properties of the strain Bifidobacterium animalis subsp. lactis CECT 8145 in Zücker fatty rats.
Carreras NL; Martorell P; Chenoll E; Genovés S; Ramón D; Aleixandre A
Benef Microbes; 2018 Jun; 9(4):629-641. PubMed ID: 29695181
[TBL] [Abstract][Full Text] [Related]
6. The effect of probiotic supplementation on the gut microbiota of preterm infants.
Plummer EL; Danielewski JA; Garland SM; Su J; Jacobs SE; Murray GL
J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34431764
[No Abstract] [Full Text] [Related]
7. Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp.
Ba Z; Lee Y; Meng H; Kris-Etherton PM; Rogers CJ; Lewis ZT; Mills DA; Furumoto EJ; Rolon ML; Fleming JA; Roberts RF
mSphere; 2021 Aug; 6(4):e0008421. PubMed ID: 34232082
[TBL] [Abstract][Full Text] [Related]
8. Probiotic Bifidobacterium animalis subsp. lactis Bi-07 alleviates bacterial translocation and ameliorates microinflammation in experimental uraemia.
Wei M; Wang Z; Liu H; Jiang H; Wang M; Liang S; Shi K; Feng J
Nephrology (Carlton); 2014 Aug; 19(8):500-6. PubMed ID: 24787732
[TBL] [Abstract][Full Text] [Related]
9. Probiotic treatment with
Joho D; Takahashi M; Suzuki T; Ikuta K; Matsumoto M; Kakeyama M
Brain Commun; 2023; 5(6):fcad311. PubMed ID: 38025274
[TBL] [Abstract][Full Text] [Related]
10. Combination of
Li SC; Hsu WF; Chang JS; Shih CK
Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035617
[TBL] [Abstract][Full Text] [Related]
11. Mortality and translocation assay to study the protective capacity of Bifidobacterium lactis INL1 against Salmonella Typhimurium infection in mice.
Zacarías MF; Reinheimer J; Forzani L; Grangette C; Vinderola G
Benef Microbes; 2014 Dec; 5(4):427-36. PubMed ID: 24902954
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional and Functional Analysis of Bifidobacterium animalis subsp. lactis Exposure to Tetracycline.
Morovic W; Roos P; Zabel B; Hidalgo-Cantabrana C; Kiefer A; Barrangou R
Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30266728
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Probiotics of
Wang CH; Yen HR; Lu WL; Ho HH; Lin WY; Kuo YW; Huang YY; Tsai SY; Lin HC
Front Endocrinol (Lausanne); 2022; 13():754401. PubMed ID: 35299968
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant probiotic Bifidobacterium animalis subsp. lactis CP-9 improve phototherapeutic treatment outcomes in neonatal jaundice among full-term newborns: A randomized double-blind clinical study.
Tsai ML; Lin WY; Chen YT; Lin HY; Ho HH; Kuo YW; Lin JH; Huang YY; Wang HS; Chiu HY; Lin HC
Medicine (Baltimore); 2022 Nov; 101(45):e31030. PubMed ID: 36397441
[TBL] [Abstract][Full Text] [Related]
15.
Liang X; Zheng X; Wang P; Zhang H; Ma Y; Liang H; Zhang Z
J Agric Food Chem; 2024 Feb; 72(5):2585-2597. PubMed ID: 38285537
[TBL] [Abstract][Full Text] [Related]
16. Adaptation and response of Bifidobacterium animalis subsp. lactis to bile: a proteomic and physiological approach.
Sánchez B; Champomier-Vergès MC; Stuer-Lauridsen B; Ruas-Madiedo P; Anglade P; Baraige F; de los Reyes-Gavilán CG; Johansen E; Zagorec M; Margolles A
Appl Environ Microbiol; 2007 Nov; 73(21):6757-67. PubMed ID: 17827318
[TBL] [Abstract][Full Text] [Related]
17. The Probiotic Combination of
Barba-Vidal E; Castillejos L; Roll VFB; Cifuentes-Orjuela G; Moreno Muñoz JA; Martín-Orúe SM
Front Microbiol; 2017; 8():1570. PubMed ID: 28861074
[TBL] [Abstract][Full Text] [Related]
18. Probiotic Therapy with
Borshchev YY; Burovenko IY; Karaseva AB; Minasian SM; Protsak ES; Borshchev VY; Semenova NY; Borshcheva OV; Suvorov AN; Galagudza MM
Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36422363
[TBL] [Abstract][Full Text] [Related]
19. Polyphasic taxonomic analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the subspecies level: reclassification of Bifidobacterium animalis as Bifidobacterium animalis subsp. animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. lactis subsp. nov.
Masco L; Ventura M; Zink R; Huys G; Swings J
Int J Syst Evol Microbiol; 2004 Jul; 54(Pt 4):1137-1143. PubMed ID: 15280282
[TBL] [Abstract][Full Text] [Related]
20. Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats.
Salazar N; Binetti A; Gueimonde M; Alonso A; Garrido P; González del Rey C; González C; Ruas-Madiedo P; de los Reyes-Gavilán CG
Int J Food Microbiol; 2011 Jan; 144(3):342-51. PubMed ID: 21078530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
